Relationship Between Everolimus Blood Concentration Assessed Using the Innofluor Certican Fluorescence Polarization Immunoassay and the Architect i System Sirolimus Chemiluminescent Microparticle Immunoassay
                        AuthID
P-003-6MC
                
    P-003-6MC
 
    
                     
    
                     
    
                     
    
                     
                    